BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 19209125)

  • 1. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroid carcinoma].
    Namba H; Izumi M
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
    Tung WS; Shevlin DW; Bartsch D; Norton JA; Wells SA; Goodfellow PJ
    Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of follicular thyroid cancer.
    Farid NR; Zou M; Shi Y
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):865-83. PubMed ID: 8608782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
    Pallante P; Visone R; Croce CM; Fusco A
    Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
    Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
    Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
    Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG; Moses AC
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial thyroid carcinoma: a diagnostic algorithm.
    Dotto J; Nosé V
    Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular basis of tumors arising in thyroid follicular cells].
    Wynford-Thomas D
    Ann Chir; 1999; 53(3):237-43. PubMed ID: 10339867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiated and medullary thyroid cancer in childhood and adolescence.
    La Quaglia MP; Telander RL
    Semin Pediatr Surg; 1997 Feb; 6(1):42-9. PubMed ID: 9117274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
    Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
    Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors.
    Perren A; Schmid S; Locher T; Saremaslani P; Bonvin C; Heitz PU; Komminoth P
    Endocr Relat Cancer; 2004 Dec; 11(4):855-60. PubMed ID: 15613458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic causes of the thyroid carcinomas].
    Jindrichová S; Vlcek P; Bendlová B
    Cas Lek Cesk; 2004; 143(10):664-8. PubMed ID: 15584614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.